We are live on ! Find out more
ORI

Oak Ridge Investments Portfolio holdings

AUM $1.77B
1-Year Est. Return 63.16%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.09%
AUM
$1.33B
AUM Growth
-$117M
Cap. Flow
-$94.7M
Cap. Flow %
-7.13%
Top 10 Hldgs %
21.28%
Holding
181
New
10
Increased
25
Reduced
125
Closed
10

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$13.9M
2
META icon
Meta Platforms (Facebook)
META
+$10.3M
3
RBC icon
RBC Bearings
RBC
+$9.51M
4
EYE icon
National Vision
EYE
+$8.43M
5
INTU icon
Intuit
INTU
+$6.48M

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 18.95%
3 Industrials 14.17%
4 Consumer Discretionary 12.77%
5 Financials 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
76
Unilever
UL
$136B
$6.7M 0.5%
99,095
-3,691
-4% -$256K
EQIX icon
77
Equinix
EQIX
$103B
$6.56M 0.49%
+11,368
New +$6.11M
INTU icon
78
Intuit
INTU
$89B
$6.26M 0.47%
+23,543
New +$6.48M
PCRX icon
79
Pacira BioSciences
PCRX
$997M
$6.18M 0.46%
162,323
-7,603
-4% -$303K
ABT icon
80
Abbott
ABT
$187B
$6.15M 0.46%
73,462
-953
-1% -$81K
AVGO icon
81
Broadcom
AVGO
$2.04T
$6.01M 0.45%
217,870
+13,730
+7% +$390K
MTDR icon
82
Matador Resources
MTDR
$6.09B
$5.59M 0.42%
338,436
-19,918
-6% -$333K
MIME
83
DELISTED
Mimecast Limited
MIME
$5.49M 0.41%
154,030
-10,153
-6% -$442K
ALXN
84
DELISTED
Alexion Pharmaceuticals
ALXN
$5.38M 0.4%
54,876
-2,705
-5% -$305K
KLAC icon
85
KLA
KLAC
$259B
$5.28M 0.4%
330,930
-6,470
-2% -$90.4K
HRTX icon
86
Heron Therapeutics
HRTX
$92.9M
$4.92M 0.37%
265,804
+157,309
+145% +$2.9M
HOMB icon
87
Home BancShares
HOMB
$6.18B
$4.74M 0.36%
252,021
-18,177
-7% -$340K
ABMD
88
DELISTED
Abiomed Inc
ABMD
$4.63M 0.35%
26,005
-355
-1% -$76.7K
EVBG
89
DELISTED
Everbridge, Inc. Common Stock
EVBG
$4.53M 0.34%
+73,370
New +$6.22M
ARGX icon
90
argenx
ARGX
$54.1B
$4.45M 0.34%
39,082
+23,398
+149% +$3.16M
EW icon
91
Edwards Lifesciences
EW
$51.7B
$4.45M 0.33%
+60,714
New +$4.26M
FTNT icon
92
Fortinet
FTNT
$117B
$4.4M 0.33%
286,525
-188,215
-40% -$3.05M
BPMC
93
DELISTED
Blueprint Medicines
BPMC
$4.13M 0.31%
56,154
+21,020
+60% +$1.82M
NOW icon
94
ServiceNow
NOW
$129B
$4.09M 0.31%
80,650
+74,260
+1,162% +$4.04M
KURA icon
95
Kura Oncology
KURA
$850M
$3.92M 0.3%
+258,755
New +$4.61M
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$126B
$3.85M 0.29%
22,731
+549
+2% +$97.1K
DLTH icon
97
Duluth Holdings
DLTH
$159M
$3.71M 0.28%
437,995
-30,981
-7% -$339K
SUPN icon
98
Supernus Pharmaceuticals
SUPN
$2.77B
$3.34M 0.25%
121,504
-11,103
-8% -$329K
EOG icon
99
EOG Resources
EOG
$70.7B
$3.25M 0.24%
43,751
-539
-1% -$43.7K
CDXS icon
100
Codexis
CDXS
$158M
$3.21M 0.24%
234,057
-45,904
-16% -$722K

Similar funds

Oak Ridge Investments's Q3 2019 Portfolio in Review

As of Q3 2019, Oak Ridge Investments held 181 positions worth $1.33B, down 8.1% from $1.45B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oak Ridge Investments withdrew a net $94.7M in Q3 2019, closing 10 positions and reducing 125 holdings. Its most notable exit was Ulta Beauty, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oak Ridge Investments opened a new position in National Vision worth $6.96M.

  • Oak Ridge Investments's largest Q3 2019 buy was National Vision: 289,321 shares worth $6.96M.
  • Oak Ridge Investments added most to Mastercard in Q3 2019, an estimated $13.9M increase.
  • Oak Ridge Investments's biggest Q3 2019 reduction was EPAM Systems, cutting an estimated $15.4M.
  • Oak Ridge Investments fully exited Ulta Beauty in Q3 2019, selling an estimated $18.1M.
  • Oak Ridge Investments's ten largest holdings make up 21% of its $1.33B portfolio in Q3 2019.
  • Oak Ridge Investments opened 10 new positions and closed 10 in Q3 2019.
  • Oak Ridge Investments's portfolio value fell 8.1% quarter-over-quarter to $1.33B.

Based on Oak Ridge Investments's 13F filing for Q3 2019, filed 7 Nov 2019.